支气管扩张剂全球市场规模、份额、成长分析、按药物类型、按给药途径划分 - 产业预测 (2024-2031)

Global Bronchodilators Market Size, Share, Growth Analysis, By Drug Type(Beta2-Adrenergic Agonists, Sympathomimetics), By Route of Administration(Oral, Injection) - Industry Forecast 2024-2031

出版日期: 2024年03月11日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球支气管扩张剂市场规模为221.9亿美元，从2023年的234.8亿美元成长到2031年的368.6亿美元，预测期（2024-2031）预计复合年增长率为5.8%。

由于支气管炎、气喘和慢性阻塞性肺病（COPD）等呼吸系统疾病的盛行率不断增加，支气管扩张剂市场正在显着扩大。支气管扩张剂药物可以扩张和放鬆肺部气道，使呼吸更容易。由于各种呼吸系统疾病的全球负担日益增加以及环境变数和生活方式的变化，对支气管扩张剂的需求正在增加。市面上有两种类型的支气管扩张剂：短效和长效，每种都为患者提供不同的用途。长效支气管扩张剂为慢性治疗提供长期效果，而短效支气管扩张剂为急性呼吸道疾病提供立即缓解。由于呼吸道疾病的高发病率、发达的医疗保健系统和不断提高的意识，北美和欧洲占据了主要市场占有率。由于人口稠密地区的污染水平上升和生活方式的改变，亚太地区正在成为一个有价值的市场。此外，干粉吸入器和定量吸入器等吸入装置的改进提高了患者的依从性和药物输送功效。由于呼吸道疾病盛行率上升，支气管扩张剂市场预计将进一步成长。这种增长是由持续的研究、创新的药物配方和製药行业内巧妙的合作伙伴关係所推动的。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Teva Pharmaceutical Industries
Novartis
Merck & Co.
Mylan NV
Sunovion Pharmaceuticals
Cipla
Vectura Group
Chiesi Farmaceutici
Mundipharma
Perrigo
Orion Corporation
Almirall

简介目录

Product Code: SQMIG35I2257

Global Bronchodilators Market size was valued at USD 22.19 billion in 2022 and is poised to grow from USD 23.48 billion in 2023 to USD 36.86 billion by 2031, growing at a CAGR of 5.8% during the forecast period (2024-2031).

The market for bronchodilators is expanding significantly as a result of the increased incidence of respiratory conditions such bronchitis, asthma, and chronic obstructive pulmonary disease (COPD). Medication known as a bronchodilator widens and relaxes the lungs' airways to facilitate breathing. The demand for bronchodilator drugs is being driven by the rising global burden of various respiratory illnesses, as well as by changing environmental variables and lifestyles. The two types of bronchodilators available on the market are short-acting and long-acting, with each serving a distinct purpose for patients. While long-acting bronchodilators give prolonged benefits for chronic treatment, short-acting bronchodilators offer immediate relief during acute respiratory issues. Due to a high incidence of respiratory illnesses, a developed healthcare system, and growing awareness, North America and Europe control significant market shares. Because of rising pollution levels and changing lifestyles in densely populated areas, the Asia-Pacific region is becoming a valuable market. Furthermore, improvements in inhalation devices-like dry powder inhalers and metered-dose inhalers-are improving patient compliance and the effectiveness of medication delivery. The market for bronchodilators is expected to grow further as the prevalence of respiratory conditions rises. This growth will be fueled by ongoing research, creative medication formulations, and clever partnerships within the pharmaceutical sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bronchodilators Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bronchodilators Market Segmental Analysis

Based on Indication, Drug Type, Route of Administration, and Region, the global market for bronchodilators is divided into segments. The market is divided into categories based on indication, including asthma, chronic obstructive pulmonary disease (COPD), and others. The market is divided into four segments based on the kind of drug: combination bronchodilators, beta2-adrenergic antagonists, anticholinergic agents, and methylxanthines. The market is divided into oral, injection, and inhaler segments based on the route of administration. The market is divided into North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa based on region.

Drivers of the Global Bronchodilators Market

The market for bronchodilators is mostly driven by the rising prevalence of respiratory conditions such bronchitis, asthma, and chronic obstructive pulmonary disease (COPD). Effective bronchodilator drugs are required for both disease management and symptom alleviation because to the increasing global burden of these illnesses.

Restraints in the Global Bronchodilators Market

Certain bronchodilators, especially those that are breathed, may cause side effects such headaches, tremors, and elevated heart rate. These side effects may cause patients to stop using the medication consistently or to stop following their treatment plans.

Market Trends of the Global Bronchodilators Market

One essential part of administering bronchodilators is using inhalation devices. Advanced inhaler technologies, such smart inhalers and digital monitoring systems, are becoming more and more popular in the market. These developments improve treatment adherence and illness management by providing real-time drug consumption monitoring and feedback to patients and medical providers.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Bronchodilators Market by Drug Type

Market Overview
Beta2-Adrenergic Agonists
Sympathomimetics
Anticholinergics
Phosphodiesterase Inhibitor
and Combination Drugs.

Global Bronchodilators Market by Route of Administration

Market Overview
Oral
Injection
and Inhaler.

Global Bronchodilators Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

GlaxoSmithKline
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sunovion Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vectura Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chiesi Farmaceutici
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mundipharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perrigo
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orion Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almirall
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments